To investigate the final dosage of OROS-methylphenidate for patients achieving optimal response in 10 weeks.The optimal response is defined as a score of 0 or 1 on each of the first 18 ADHD items (referred to SNAP-IV (Swanson, Nolan and Pelham)) [clinicaltrials_resource:223ca0080f7afcc3d219973a66522347]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To investigate the final dosage of OROS-methylphenidate for patients achieving optimal response in 10 weeks.The optimal response is defined as a score of 0 or 1 on each of the first 18 ADHD items (referred to SNAP-IV (Swanson, Nolan and Pelham)) [clinicaltrials_resource:223ca0080f7afcc3d219973a66522347]
Bio2RDF identifier
223ca0080f7afcc3d219973a66522347
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:223ca0080f7afcc3d219973a66522347
measure [clinicaltrials_vocabulary:measure]
To investigate the final dosag ...... V (Swanson, Nolan and Pelham))
identifier
clinicaltrials_resource:223ca0080f7afcc3d219973a66522347
title
To investigate the final dosag ...... V (Swanson, Nolan and Pelham))
@en
type
label
To investigate the final dosag ...... ca0080f7afcc3d219973a66522347]
@en